From Mycosynthesis to Immunomodulation: Exploring the Safety, Adjuvant Potential and Microbiota Impact of Biogenic Silver Nanoparticles
Microbial Biotechnology · 2026-07 · 19 (7)
DOI: 10.1111/1751-7915.70411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Biotechnology, online erschienen am 10.07.2026. Verfasst von Ana Clara Muniz-Lagos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Área de Microbiología, Departamento de Biociencias, Facultad de Química, Universidad de la República, Montevideo, Uruguay. Hauptthemen laut MEDLINE: Silver, Metal Nanoparticles, Adjuvants, Immunologic, Immunomodulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agencia Nacional de Investigación e Innovación, Comisión Sectorial de Investigación Científica, Universidad de la República Uruguay.
Abstract (Originalsprache)
Subunit vaccines are considered the safest immunization platforms but typically require adjuvants to elicit robust immune responses. Although nanoparticles have emerged as promising adjuvants, biogenic silver nanoparticles (AgNPs) produced by mycosynthesis remain largely unexplored. Herein, nine different AgNPs were mycosynthesized using local strains of Phanerochaete chrysosporium , Penicillium expansum and Punctularia atropurpurascens grown in three different culture media (PDB, MEB, MGYP). Mycosynthesized AgNPs were all shown to be spherical, negatively charged and containing fungal proteins within the biomolecular capping. Additionally, although in vitro biocompatibility assessments showed AgNPs‐specific differences in haemolytic and cytotoxic activities, no signs of acute toxicity were observed in mice. The adjuvant potential of AgNPs was further evaluated in ovalbumin‐immunized mice, showing that four AgNPs displayed significant immunoenhancement activity with an outstanding IgG 2a ‐polarizaing effect. Adjuvant and IgG subclass polarizing activities were both shown to be dose dependent. Finally, distal effects induced by selected AgNPs were assessed through faecal microbiota analyses. Remarkably, while Firmicutes and Bacteroidota remained the dominant phyla, AgNPs‐treated groups showed compositional shifts consistent with mild immunomodulation. Summing up, our results on biocompatibility, adjuvant capacity, strong and dose‐dependent IgG 2a ‐polarizing activity, as well as limited impact on gut microbiota, support mycosynthesized AgNPs as versatile next‐generation platforms for developing novel vaccine adjuvants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Área de Microbiología, Departamento de Biociencias, Facultad de Química, Universidad de la República, Montevideo, Uruguay.
- Área Inmunología, Departamento de Biociencias, Facultad de Química, Universidad de la República, Montevideo, Uruguay.
- Unidad Asociada de Inmunología, Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay.
- Laboratorio de Inmunología, Instituto de Higiene "Prof. Arnoldo Berta", Universidad de la República, Montevideo, Uruguay.
ORCID-Profile: Ana Clara Muniz-Lagos, Diego M Roldán, Paula Arbildi, Gustavo Mourglia-Ettlin, Silvana Alborés
Förderung
- Agencia Nacional de Investigación e Innovación
- Comisión Sectorial de Investigación Científica
- Universidad de la República Uruguay
- Programa de Desarrollo de las Ciencias Básicas
Zitieren
APA
Muniz-Lagos, A. C., Roldán, D. M., Arbildi, P., Mourglia-Ettlin, G., & Alborés, S. (2026). From Mycosynthesis to Immunomodulation: Exploring the Safety, Adjuvant Potential and Microbiota Impact of Biogenic Silver Nanoparticles. Microbial Biotechnology, 19(7). https://doi.org/10.1111/1751-7915.70411
Vancouver
Muniz-Lagos AC, Roldán DM, Arbildi P, Mourglia-Ettlin G, Alborés S. From Mycosynthesis to Immunomodulation: Exploring the Safety, Adjuvant Potential and Microbiota Impact of Biogenic Silver Nanoparticles. Microbial Biotechnology. 2026;19(7). doi:10.1111/1751-7915.70411
BibTeX
@article{MunizLagos2026,
author = {Muniz-Lagos, Ana Clara and Roldán, Diego M and Arbildi, Paula and Mourglia-Ettlin, Gustavo and Alborés, Silvana},
title = {From Mycosynthesis to Immunomodulation: Exploring the Safety, Adjuvant Potential and Microbiota Impact of Biogenic Silver Nanoparticles},
journal = {Microbial Biotechnology},
year = {2026},
volume = {19},
number = {7},
doi = {10.1111/1751-7915.70411}
}
EUVIMED